Surufatinib Uses, Dosage, Side Effects and more
Surufatinib is under investigation in clinical trial NCT02588170 (Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors).
| Attribute | Details |
|---|---|
| Trade Name | Surufatinib |
| Generic | Surufatinib |
| Surufatinib Other Names | SULFATINIB, Surufatinib |
| Type | |
| Formula | C24H28N6O3S |
| Weight | Average: 480.59 Monoisotopic: 480.19435996 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Innovators Monograph
Search Medicines
